Literature DB >> 30674496

Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia.

Tarek Haykal1, Saira Sundus1, Ghassan Bachuwa1, Rizwan Danish1.   

Abstract

This is a case of a 67-year-old woman, known to have multiple medical problems, mainly papillary thyroid cancer status post-total thyroidectomy and cervical neck dissection in addition to radioactive iodine currently in remission for 1 year, who presented to the hospital with severe weakness and fatigue. The initial workup showed significant hypercalcaemia and suppressed Parathyroid hormone (PTH). The patient was treated with hydration and pamidronate and her hypercalcaemia and symptoms improved. The differential was wide, however, a CT scan of the chest, abdomen and pelvis did show multiple liver and splenic nodular lesions; therefore, malignancy was the highest possible diagnosis. Biopsy of the splenic lesion confirmed the diagnosis of sarcoidosis. Therefore, the patient was diagnosed with primary isolated nodular hepatosplenic sarcoidosis mimicking malignancy and causing significant symptomatic hypercalcaemia. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  calcium and bone; endocrinology; rheumatology

Mesh:

Substances:

Year:  2019        PMID: 30674496      PMCID: PMC6347923          DOI: 10.1136/bcr-2018-227703

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Anti-TNF-α for necrotizing sarcoid granulomatosis of the liver.

Authors:  Marcial Sebode; Sören Weidemann; Malte Wehmeyer; Ansgar W Lohse; Christoph Schramm
Journal:  Hepatology       Date:  2017-02-03       Impact factor: 17.425

Review 2.  Sarcoidosis.

Authors:  Nabeel Hamzeh
Journal:  Med Clin North Am       Date:  2011-10-05       Impact factor: 5.456

Review 3.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

4.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

5.  Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia.

Authors:  Mohammad Shafi Kuchay; Sunil Kumar Mishra; Beena Bansal; Khalid Jamal Farooqui; Lalitha Sekhar; Ambrish Mithal
Journal:  Arch Osteoporos       Date:  2017-07-19       Impact factor: 2.617

Review 6.  Approaches to the treatment of some of the troublesome manifestations of sarcoidosis.

Authors:  A Eklund; R M du Bois
Journal:  J Intern Med       Date:  2014-02-05       Impact factor: 8.989

Review 7.  Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis: A New Entity? (A Case-Series).

Authors:  Arthur Mageau; Aude Rigolet; Khadija Benali; Maria Chauchard; Salima Ladjeroud; Isabelle Mahe; Thierry Maisonobe; Marie-Paule Chauveheid; Thomas Papo; Karim Sacre
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Localized hepatosplenic sarcoidosis with an elevated serum CA-125 level.

Authors:  Ramin S Herati; Joyce M Koh; Emmanuel C Gorospe
Journal:  ScientificWorldJournal       Date:  2010-02-17

Review 9.  Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice.

Authors:  Claudio Tana; Christoph F Dietrich; Cosima Schiavone
Journal:  Biomed Res Int       Date:  2014-08-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.